Assessing ART Resistance and Clinical Outcomes of Children and Adolescents Transitioning to DTG based ARV Regimen in Homa Bay, Kenya
Overview
Kenya
Pediatric and Adolescent Testing, Care, and Treatment
The primary goal of this ELMA -funded study is to estimate the proportion of ART resistance among treatment-experienced children and adolescents who transitioned to DTG-based regimens in Homa Bay, Kenya. The study utilizes an observational prospective cohort of children and adolescents to assess ART resistance and explore the clinical, immunologic, and virologic outcomes at 3 and 6 months following transition to a DTG-based regimen.
Data Collection Period: 11/2021 – 08/2022